Megan O’Grady

865 total citations
9 papers, 404 citations indexed

About

Megan O’Grady is a scholar working on Molecular Biology, Biochemistry and Cellular and Molecular Neuroscience. According to data from OpenAlex, Megan O’Grady has authored 9 papers receiving a total of 404 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 3 papers in Biochemistry and 2 papers in Cellular and Molecular Neuroscience. Recurrent topics in Megan O’Grady's work include Genomics, phytochemicals, and oxidative stress (3 papers), Mitochondrial Function and Pathology (2 papers) and Dermatology and Skin Diseases (2 papers). Megan O’Grady is often cited by papers focused on Genomics, phytochemicals, and oxidative stress (3 papers), Mitochondrial Function and Pathology (2 papers) and Dermatology and Skin Diseases (2 papers). Megan O’Grady collaborates with scholars based in United States, Australia and Austria. Megan O’Grady's co-authors include Colin J. Meyer, Melanie Chin, George L. Bakris, David G. Warnock, Angie Goldsberry, Keith W. Ward, Scott A. Reisman, Christoph Wanner, Nosratola D. Vaziri and Geoffrey A. Block and has published in prestigious journals such as Neurology, CHEST Journal and Movement Disorders.

In The Last Decade

Megan O’Grady

9 papers receiving 397 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Megan O’Grady United States	6	268	70	53	39	38	9	404
Jung Eun Kim South Korea	10	150 0.6×	75 1.1×	39 0.7×	74 1.9×	40 1.1×	11	429
Katharina Krueger Germany	12	141 0.5×	28 0.4×	22 0.4×	20 0.5×	28 0.7×	18	457
Siping Xiong China	12	218 0.8×	40 0.6×	19 0.4×	25 0.6×	31 0.8×	22	501
Dóra Balogh Hungary	10	158 0.6×	60 0.9×	40 0.8×	119 3.1×	28 0.7×	22	344
N. Eleno Spain	12	158 0.6×	59 0.8×	42 0.8×	17 0.4×	35 0.9×	21	425
Bernard Ferrier France	14	245 0.9×	121 1.7×	24 0.5×	67 1.7×	73 1.9×	33	517
Bridget Ford United States	11	410 1.5×	130 1.9×	39 0.7×	71 1.8×	174 4.6×	15	728
Hua-feng Liu China	12	136 0.5×	72 1.0×	11 0.2×	20 0.5×	22 0.6×	22	338
Mee Young Choi South Korea	12	238 0.9×	23 0.3×	23 0.4×	17 0.4×	15 0.4×	16	372
Ana M. Rodrı́guez-López Spain	11	159 0.6×	55 0.8×	16 0.3×	15 0.4×	10 0.3×	21	380

Countries citing papers authored by Megan O’Grady

Since Specialization

Citations

This map shows the geographic impact of Megan O’Grady's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Megan O’Grady with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Megan O’Grady more than expected).

Fields of papers citing papers by Megan O’Grady

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Megan O’Grady. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Megan O’Grady. The network helps show where Megan O’Grady may publish in the future.

Co-authorship network of co-authors of Megan O’Grady

This figure shows the co-authorship network connecting the top 25 collaborators of Megan O’Grady. A scholar is included among the top collaborators of Megan O’Grady based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Megan O’Grady. Megan O’Grady is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Lynch, David R., Melanie Chin, Sylvia Boesch, et al.. (2022). Efficacy of Omaveloxolone in Friedreich's Ataxia: Delayed‐Start Analysis of the MOXIe Extension. Movement Disorders. 38(2). 313–320. 55 indexed citations

Madsen, Karen L., Bruce H. Cohen, Marni J. Falk, et al.. (2020). Safety and efficacy of omaveloxolone in patients with mitochondrial myopathy. Neurology. 94(7). e687–e698. 43 indexed citations

Lynch, David R., Melanie Chin, Martin Delatycki, et al.. (2020). Safety and Efficacy of Omaveloxolone in Friedreich's Ataxia (MOXIe Study): A Multicentre, Randomised, Double-Blind, Placebo-Controlled Trial. SSRN Electronic Journal. 1 indexed citations

Chin, Melanie, George L. Bakris, Geoffrey A. Block, et al.. (2018). Bardoxolone Methyl Improves Kidney Function in Patients with Chronic Kidney Disease Stage 4 and Type 2 Diabetes: Post-Hoc Analyses from Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes Study. American Journal of Nephrology. 47(1). 40–47. 129 indexed citations

Oudiz, Ronald J., Colin J. Meyer, Melanie Chin, et al.. (2015). Initial Data Report from “LARIAT”: A Phase 2 Study of Bardoxolone Methyl in PAH Patients on Stable Background Therapy. CHEST Journal. 148(4). 639A–639A. 17 indexed citations

Reisman, Scott A., Chun‐Yue I. Lee, Megan O’Grady, et al.. (2015). Topical application of RTA 408 lotion activates Nrf2 in human skin and is well-tolerated by healthy human volunteers. BMC Dermatology. 15(1). 10–10. 27 indexed citations

Chin, Melanie, Scott A. Reisman, George L. Bakris, et al.. (2014). Mechanisms Contributing to Adverse Cardiovascular Events in Patients with Type 2 Diabetes Mellitus and Stage 4 Chronic Kidney Disease Treated with Bardoxolone Methyl. American Journal of Nephrology. 39(6). 499–508. 125 indexed citations

Stroud, R. M., Megan O’Grady, L. R. Nittler, & C. M. O'd. Alexander. (2002). Transmission Electron Microscopy of an In Situ Presolar Silicon Carbide Grain. 1785. 4 indexed citations

Stroud, R. M., Megan O’Grady, L. R. Nittler, & C. M. O'd. Alexander. (2002). Electron Microscopy of In Situ Presolar Silicon Carbide. Microscopy and Microanalysis. 8(S02). 1550–1551. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact